BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aptel Research Launches Unique Patient-centric Syndicated Report Series That Analyze the Patient Journey for Chronic Diseases in Specialty Markets


9/16/2013 11:01:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass., Sept. 16, 2013 /PRNewswire/ -- Aptel Research, a specialty marketing research and consulting company that provides actionable strategic insights to the pharmaceutical and biotech industries, today launched Patient Voices Syndicated Report Series. Patient Voices Syndicated Report Series provides rich insights into the emotional and rational factors that impact the patient journey through specific chronic diseases in specialty markets. The first report covers multiple sclerosis in the United States. Future reports will cover other chronic diseases in the U.S. and in international markets. Each report captures the various aspects of the patient journey from symptoms to diagnosis to treatment, and identifies issues and gaps along the way. The reports employ a mix of qualitative interviews, quantitative surveys, and an analysis of patient social media to create a nuanced understanding of patients' experiences, as well as brand attitudes and unmet needs.

"Patients with relapsing forms of MS are fortunate to have many treatment options now, including oral treatments," said Aptel Research CEO Michele Derai. "The MS landscape is rapidly changing and additional multiple sclerosis agents are in various stages of development in the U.S. and abroad. The Patient Voices Syndicated Report Series will serve the product life-cycle needs of our clients by allowing them to differentiate their products to best match patients' lives and mindsets at any point in their journey. The insights provided by the Patient Voices Syndicated Report Series will enable our clients to uncover new marketing opportunities."

With decades of experience, in-depth business and scientific expertise and a global network, Aptel Research offers customized strategic market research from market assessment to branding strategy with key target audiences, including key opinion leaders.

For more information visit Aptel Research.

Media contact: Jane A. Kramer 781-799-9524

SOURCE Aptel Research



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES